VIVID, VISTA trials: Aflibercept superior to laser treatment for DME | OSN Retina

[ad_1]
Another antiVEGF intravitreal injection looks promising for the treatment of diabetic macular edema.

VIVID, VISTA trials: Aflibercept superior to laser treatment for DME | OSN Retina

OSN Retina | NEW ORLEANS — Parallel studies testing separate regimens of aflibercept injections against laser photocoagulation found both drug regimens to work better than laser photocoagulation in patients with diabetic macular edema. Reporting the primary results at 1 year of the VIVID and V…
[ad_2]

Return to main website.